Incorporating MDMA as an Adjunct in Emotionally Focused Couples Therapy With Clients Impacted by Trauma or PTSD
The Family Journal July 1, 2019 Katie Almond, Robert Allan 7 citations
This article proposes integrating MDMA as an adjunct to emotionally focused couples therapy (EFT) for couples where at least one partner has experienced trauma and shows PTSD symptoms. Although MDMA is a Schedule I drug, the FDA designated it a breakthrough therapy for PTSD in 2017 and approved a Phase 3 clinical trial. The article combines existing research on MDMA-assisted psychotherapy with the systemic, evidence-based EFT approach to treat PTSD within a couple's context.